Gene · 3959
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum Insulin-Like Growth Factor 1 Levels, Facture Risk Assessment Tool Scores and Bone Disorders in Patients with Primary Biliary Cholangitis. | Diagnostics (Basel) | 2022 | 36010307 | PubTator, text mining | PubMed |
| Gene Ontology Analysis Highlights Biological Processes Influencing Non-Response to Anti-TNF Therapy in Rheumatoid Arthritis. | Biomedicines | 2022 | 36009355 | PubTator, text mining | PubMed |
| Tamoxifen-resistant breast cancer cells exhibit reactivity with Wisteria floribunda agglutinin. | PLoS One | 2022 | 36006984 | PubTator, text mining | PubMed |
| Liquid Biopsy and Circulating Biomarkers for the Diagnosis of Precancerous and Cancerous Oral Lesions. | Noncoding RNA | 2022 | 36005828 | PubTator, text mining | PubMed |
| Editorial: Association of novel anthropometric indexes with metabolic syndrome. | Front Endocrinol (Lausanne) | 2022 | 36004337 | PubTator, text mining | PubMed |
| Utility of serum and salivary lactate dehydrogenase and uric acid levels as a diagnostic profile in oral squamous cell carcinoma patients. | J Oral Maxillofac Pathol | 2022 | 35968187 | PubTator, text mining | PubMed |
| Maternal vaccination as an additional approach to improve the protection of the nursling: Anti-infective properties of breast milk. | Clinics (Sao Paulo) | 2022 | 35963149 | PubTator, text mining | PubMed |
| Liver cancer risk-predictive molecular biomarkers specific to clinico-epidemiological contexts. | Adv Cancer Res | 2022 | 35961696 | PubTator, text mining | PubMed |
| Longitudinal Serum Proteome Characterization of COVID-19 Patients With Different Severities Revealed Potential Therapeutic Strategies. | Front Immunol | 2022 | 35958562 | PubTator, text mining | PubMed |
| Proteomic analysis of plasma exosomes in patients with non-small cell lung cancer. | Transl Lung Cancer Res | 2022 | 35958340 | PubTator, text mining | PubMed |
| Biochemical and Biophysical Characterization of Carbonic Anhydrase VI from Human Milk and Saliva. | Protein J | 2022 | 35947329 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| Serum angiopoietin-2 levels predict regression of Mac-2 binding protein glycosylation isomer-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents. | Hepatol Res | 2022 | 35938598 | PubTator, text mining | PubMed |
| Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy. | Front Immunol | 2022 | 35936007 | PubTator, text mining | PubMed |
| Association Between Plasma Exosomes S100A9/C4BPA and Latent Tuberculosis Infection Treatment: Proteomic Analysis Based on a Randomized Controlled Study. | Front Microbiol | 2022 | 35935235 | PubTator, text mining | PubMed |
| Single-cell transcriptome and cell type-specific molecular pathways of human non-alcoholic steatohepatitis. | Sci Rep | 2022 | 35931712 | PubTator, text mining | PubMed |
| The involvement of gut microbiota in the anti-tumor effect of carnosic acid via IL-17 suppression in colorectal cancer. | Chem Biol Interact | 2022 | 35926579 | PubTator, text mining | PubMed |
| αvβ1 integrin is enriched in extracellular vesicles of metastatic breast cancer cells: A mechanism mediated by galectin-3. | J Extracell Vesicles | 2022 | 35923105 | PubTator, text mining | PubMed |
| Targeting HECTD3-IKKα axis inhibits inflammation-related metastasis. | Signal Transduct Target Ther | 2022 | 35918322 | PubTator, text mining | PubMed |
| Role of Mitochondria in Retinal Pigment Epithelial Aging and Degeneration. | Front Aging | 2022 | 35912040 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3959/papers?page=30